MARKER THERAPEUTICS, INC. (MRKR) Net margin 2017–2025
MARKER THERAPEUTICS, INC. (MRKR) net profit margin by fiscal year — reported net income divided by reported revenue.
-343.0%FY2025 · since FY2017: -5999.1% → -343.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -343.0% | -180.1 pp |
| FY2024 | -162.8% | +85.9 pp |
| FY2023 | -248.8% | +603.1 pp |
| FY2022 | -851.9% | — |
| FY2020 | -5741.2% | +4309.7 pp |
| FY2019 | -10050.9% | +61775.4 pp |
| FY2018 | -71826.3% | -65827.2 pp |
| FY2017 | -5999.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More MRKR financial trends
MRKR RevenueMRKR Net incomeMRKR Gross profitMRKR Gross marginMRKR Operating incomeMRKR Operating marginMRKR Operating cash flowMRKR Free cash flowMRKR Capital expendituresMRKR Return on equityMRKR Stock buybacksMRKR Dividends paidMRKR Total assetsMRKR Total liabilitiesMRKR Shareholders’ equityMRKR overview →